OKYO Pharma (OKYO) to Showcase Advances at Ophthalmology Futures Forum and ESCRS iNovation Day Amid Phase 3 NEPTUNE Trial Progress

1 source ·1 article ·Sep 9, 11:00 UTC OKYO Pharma

OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical firm specializing in neuropathic corneal pain and anterior segment eye disorders, has revealed plans to present at two prominent European ophthalmology conferences in Lo…

Covered by 1 outlet

Kalkinemedia 1

All coverage · 1 article

Kalkine Media UK ·Sep 9, 11:00 UTC

OKYO Pharma (OKYO) to Showcase Advances at Ophthalmology Futures Forum and ESCRS iNovation Day Amid Phase 3 NEPTUNE Trial Progress

OKYO Pharma (OKYO) to Showcase Advances at Ophthalmology Futures Forum and ESCRS iNovation Day Amid Phase 3 NEPTUNE Trial Progress →

OKYO Pharma (OKYO) to Showcase Advances at Ophthalmology Futures Forum and ESCRS iNovation Day Amid Phase 3 NEPTUNE Trial Progress